The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Delivery Vaccines Market Research Report 2025
Synopsis
Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
Global Oral Delivery Vaccines market is projected to reach US$ 3592.1 million in 2029, increasing from US$ 2510 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Delivery Vaccines market research.
The oral vaccination market is primarily driven by the advantages it offers in terms of ease of administration, increased patient compliance, and cost-effectiveness compared to traditional injectable vaccines. Oral vaccines provide a non-invasive and painless immunization method, particularly beneficial for pediatric and elderly populations. Additionally, their potential to elicit both systemic and mucosal immunity enhances protection against pathogens that enter the body through mucosal surfaces, such as the respiratory and gastrointestinal tracts, further fueling their adoption. However, the market also faces challenges, including the complex formulation and delivery of oral vaccines, which may affect their stability and efficacy. Developing vaccines that can withstand acidic environments and enzymatic degradation in the gastrointestinal tract poses significant scientific and manufacturing challenges. Moreover, gaining regulatory approvals and ensuring public acceptance of oral vaccines may require extensive clinical data and educational efforts to dispel misconceptions about their safety and efficacy. To overcome these challenges, the industry is focused on research and innovation to improve oral vaccine formulation and delivery technologies. Collaborations between vaccine developers, research institutions, and regulatory authorities are crucial in driving the growth of the oral vaccination market and expanding access to effective and accessible immunization options, particularly in regions with limited healthcare infrastructure.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral Delivery Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Segment by Application
Public
Private
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral Delivery Vaccines report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
Global Oral Delivery Vaccines market is projected to reach US$ 3592.1 million in 2029, increasing from US$ 2510 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Delivery Vaccines market research.
The oral vaccination market is primarily driven by the advantages it offers in terms of ease of administration, increased patient compliance, and cost-effectiveness compared to traditional injectable vaccines. Oral vaccines provide a non-invasive and painless immunization method, particularly beneficial for pediatric and elderly populations. Additionally, their potential to elicit both systemic and mucosal immunity enhances protection against pathogens that enter the body through mucosal surfaces, such as the respiratory and gastrointestinal tracts, further fueling their adoption. However, the market also faces challenges, including the complex formulation and delivery of oral vaccines, which may affect their stability and efficacy. Developing vaccines that can withstand acidic environments and enzymatic degradation in the gastrointestinal tract poses significant scientific and manufacturing challenges. Moreover, gaining regulatory approvals and ensuring public acceptance of oral vaccines may require extensive clinical data and educational efforts to dispel misconceptions about their safety and efficacy. To overcome these challenges, the industry is focused on research and innovation to improve oral vaccine formulation and delivery technologies. Collaborations between vaccine developers, research institutions, and regulatory authorities are crucial in driving the growth of the oral vaccination market and expanding access to effective and accessible immunization options, particularly in regions with limited healthcare infrastructure.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral Delivery Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Segment by Application
Public
Private
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral Delivery Vaccines report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Oral Delivery Vaccines Market Overview
1.1 Product Overview and Scope of Oral Delivery Vaccines
1.2 Oral Delivery Vaccines Segment by Type
1.2.1 Global Oral Delivery Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 Rotavirus Vaccine
1.2.3 Cholera Vaccine
1.2.4 Oral Polio Vaccine
1.3 Oral Delivery Vaccines Segment by Application
1.3.1 Global Oral Delivery Vaccines Market Value by Application: (2023-2029)
1.3.2 Public
1.3.3 Private
1.4 Global Oral Delivery Vaccines Market Size Estimates and Forecasts
1.4.1 Global Oral Delivery Vaccines Revenue 2018-2029
1.4.2 Global Oral Delivery Vaccines Sales 2018-2029
1.4.3 Global Oral Delivery Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Oral Delivery Vaccines Market Competition by Manufacturers
2.1 Global Oral Delivery Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oral Delivery Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oral Delivery Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Oral Delivery Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oral Delivery Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Delivery Vaccines, Product Type & Application
2.7 Oral Delivery Vaccines Market Competitive Situation and Trends
2.7.1 Oral Delivery Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Delivery Vaccines Players Market Share by Revenue
2.7.3 Global Oral Delivery Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Delivery Vaccines Retrospective Market Scenario by Region
3.1 Global Oral Delivery Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oral Delivery Vaccines Global Oral Delivery Vaccines Sales by Region: 2018-2029
3.2.1 Global Oral Delivery Vaccines Sales by Region: 2018-2023
3.2.2 Global Oral Delivery Vaccines Sales by Region: 2024-2029
3.3 Global Oral Delivery Vaccines Global Oral Delivery Vaccines Revenue by Region: 2018-2029
3.3.1 Global Oral Delivery Vaccines Revenue by Region: 2018-2023
3.3.2 Global Oral Delivery Vaccines Revenue by Region: 2024-2029
3.4 North America Oral Delivery Vaccines Market Facts & Figures by Country
3.4.1 North America Oral Delivery Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oral Delivery Vaccines Sales by Country (2018-2029)
3.4.3 North America Oral Delivery Vaccines Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Delivery Vaccines Market Facts & Figures by Country
3.5.1 Europe Oral Delivery Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oral Delivery Vaccines Sales by Country (2018-2029)
3.5.3 Europe Oral Delivery Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Delivery Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Delivery Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oral Delivery Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Oral Delivery Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Delivery Vaccines Market Facts & Figures by Country
3.7.1 Latin America Oral Delivery Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oral Delivery Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Oral Delivery Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Delivery Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Delivery Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oral Delivery Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oral Delivery Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Delivery Vaccines Sales by Type (2018-2029)
4.1.1 Global Oral Delivery Vaccines Sales by Type (2018-2023)
4.1.2 Global Oral Delivery Vaccines Sales by Type (2024-2029)
4.1.3 Global Oral Delivery Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Oral Delivery Vaccines Revenue by Type (2018-2029)
4.2.1 Global Oral Delivery Vaccines Revenue by Type (2018-2023)
4.2.2 Global Oral Delivery Vaccines Revenue by Type (2024-2029)
4.2.3 Global Oral Delivery Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Oral Delivery Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Oral Delivery Vaccines Sales by Application (2018-2029)
5.1.1 Global Oral Delivery Vaccines Sales by Application (2018-2023)
5.1.2 Global Oral Delivery Vaccines Sales by Application (2024-2029)
5.1.3 Global Oral Delivery Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Oral Delivery Vaccines Revenue by Application (2018-2029)
5.2.1 Global Oral Delivery Vaccines Revenue by Application (2018-2023)
5.2.2 Global Oral Delivery Vaccines Revenue by Application (2024-2029)
5.2.3 Global Oral Delivery Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Oral Delivery Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Oral Delivery Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Oral Delivery Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Oral Delivery Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GSK Oral Delivery Vaccines Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Oral Delivery Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi Oral Delivery Vaccines Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Lanzhou Institute
6.4.1 Lanzhou Institute Corporation Information
6.4.2 Lanzhou Institute Description and Business Overview
6.4.3 Lanzhou Institute Oral Delivery Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lanzhou Institute Oral Delivery Vaccines Product Portfolio
6.4.5 Lanzhou Institute Recent Developments/Updates
6.5 Serum Institute
6.5.1 Serum Institute Corporation Information
6.5.2 Serum Institute Description and Business Overview
6.5.3 Serum Institute Oral Delivery Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Serum Institute Oral Delivery Vaccines Product Portfolio
6.5.5 Serum Institute Recent Developments/Updates
6.6 Valneva
6.6.1 Valneva Corporation Information
6.6.2 Valneva Description and Business Overview
6.6.3 Valneva Oral Delivery Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Valneva Oral Delivery Vaccines Product Portfolio
6.6.5 Valneva Recent Developments/Updates
6.7 Shanghai United Cell
6.6.1 Shanghai United Cell Corporation Information
6.6.2 Shanghai United Cell Description and Business Overview
6.6.3 Shanghai United Cell Oral Delivery Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shanghai United Cell Oral Delivery Vaccines Product Portfolio
6.7.5 Shanghai United Cell Recent Developments/Updates
6.8 Bibcol
6.8.1 Bibcol Corporation Information
6.8.2 Bibcol Description and Business Overview
6.8.3 Bibcol Oral Delivery Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bibcol Oral Delivery Vaccines Product Portfolio
6.8.5 Bibcol Recent Developments/Updates
6.9 PaxVax
6.9.1 PaxVax Corporation Information
6.9.2 PaxVax Description and Business Overview
6.9.3 PaxVax Oral Delivery Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.9.4 PaxVax Oral Delivery Vaccines Product Portfolio
6.9.5 PaxVax Recent Developments/Updates
6.10 Vabiotech
6.10.1 Vabiotech Corporation Information
6.10.2 Vabiotech Description and Business Overview
6.10.3 Vabiotech Oral Delivery Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Vabiotech Oral Delivery Vaccines Product Portfolio
6.10.5 Vabiotech Recent Developments/Updates
6.11 Tiantan Biological
6.11.1 Tiantan Biological Corporation Information
6.11.2 Tiantan Biological Oral Delivery Vaccines Description and Business Overview
6.11.3 Tiantan Biological Oral Delivery Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Tiantan Biological Oral Delivery Vaccines Product Portfolio
6.11.5 Tiantan Biological Recent Developments/Updates
6.12 EuBiologics
6.12.1 EuBiologics Corporation Information
6.12.2 EuBiologics Oral Delivery Vaccines Description and Business Overview
6.12.3 EuBiologics Oral Delivery Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.12.4 EuBiologics Oral Delivery Vaccines Product Portfolio
6.12.5 EuBiologics Recent Developments/Updates
6.13 Panacea Biotec Ltd
6.13.1 Panacea Biotec Ltd Corporation Information
6.13.2 Panacea Biotec Ltd Oral Delivery Vaccines Description and Business Overview
6.13.3 Panacea Biotec Ltd Oral Delivery Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Panacea Biotec Ltd Oral Delivery Vaccines Product Portfolio
6.13.5 Panacea Biotec Ltd Recent Developments/Updates
6.14 Bio-Med
6.14.1 Bio-Med Corporation Information
6.14.2 Bio-Med Oral Delivery Vaccines Description and Business Overview
6.14.3 Bio-Med Oral Delivery Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Bio-Med Oral Delivery Vaccines Product Portfolio
6.14.5 Bio-Med Recent Developments/Updates
6.15 Halfkin Bio-Pharmaceuticals
6.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.15.2 Halfkin Bio-Pharmaceuticals Oral Delivery Vaccines Description and Business Overview
6.15.3 Halfkin Bio-Pharmaceuticals Oral Delivery Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Halfkin Bio-Pharmaceuticals Oral Delivery Vaccines Product Portfolio
6.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Delivery Vaccines Industry Chain Analysis
7.2 Oral Delivery Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Delivery Vaccines Production Mode & Process
7.4 Oral Delivery Vaccines Sales and Marketing
7.4.1 Oral Delivery Vaccines Sales Channels
7.4.2 Oral Delivery Vaccines Distributors
7.5 Oral Delivery Vaccines Customers
8 Oral Delivery Vaccines Market Dynamics
8.1 Oral Delivery Vaccines Industry Trends
8.2 Oral Delivery Vaccines Market Drivers
8.3 Oral Delivery Vaccines Market Challenges
8.4 Oral Delivery Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
